Regulon

Regulon: R-1224

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
17-1.445110Pr-65Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
10181 ENSG00000003756 RBM5 P52756
55692 ENSG00000007392 LUC7L Q1W6G4
5980 ENSG00000009413 REV3L O60673
23033 ENSG00000083097 DOPEY1 Q5JWR5
8874 ENSG00000102606 ARHGEF7 Q14155
11278 ENSG00000118922 KLF12 Q9Y4X4
2891 ENSG00000120251 GRIA2 P42262
4752 ENSG00000136098 NEK3 F8VTT4
55716 ENSG00000139636 LMBR1L Q6UX01
26045 ENSG00000146006 LRRTM2 O43300
8473 ENSG00000147162 OGT O15294
6935 ENSG00000148516 ZEB1 P37275
4325 ENSG00000156103 MMP16 P51512
56339 ENSG00000165819 METTL3 Q86U44
57162 ENSG00000197329 PELI1 Q96FA3
81856 ENSG00000213020 ZNF611 Q8N823
6598 ENSG00000275837 SMARCB1 G5E975

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
MK-8777GRIA3Small moleculePOSITIVE ALLOSTERIC MODULATORGlutamate receptor ionotropic AMPA positive allosteric modulator20
PERAMPANELGRIA3Small moleculeANTAGONISTGlutamate receptor ionotropic AMPA antagonist40
PF-04958242GRIA3Small moleculePOSITIVE ALLOSTERIC MODULATORGlutamate receptor ionotropic AMPA positive allosteric modulator20
TEZAMPANELGRIK4Small moleculeANTAGONISTGlutamate receptor ionotropic kainate antagonist20
SELURAMPANELGRIK4Small moleculeANTAGONISTGlutamate receptor ionotropic kainate antagonist20
TALAMPANELGRIA2Small moleculeANTAGONISTGlutamate receptor ionotropic, AMPA 2 antagonist22
FARAMPATORGRIA3Small moleculePOSITIVE ALLOSTERIC MODULATORGlutamate receptor ionotropic AMPA positive allosteric modulator20
ZONAMPANELGRIA3Small moleculeANTAGONISTGlutamate receptor ionotropic AMPA antagonist20
TAK-653GRIA3Small moleculePOSITIVE ALLOSTERIC MODULATORGlutamate receptor ionotropic AMPA positive allosteric modulator20
TOPIRAMATECA4Small moleculePOSITIVE MODULATORGABA-A receptor; anion channel positive modulator40
MIBAMPATORGRIA3Small moleculePOSITIVE ALLOSTERIC MODULATORGlutamate receptor ionotropic AMPA positive allosteric modulator20

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-1224

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs